Medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, NeuroOne has announced the appointment of Dr. Camilo Andres Diaz-Botia as Director of Electrode Development. Dr. Diaz-Botia will report directly to NeuroOne President and CEO Dave Rosa.
Dr. Diaz-Botia joins the team at NeuroOne from Neuralink a high bandwidth brain-machine interface company founded by Elon Musk. At Neuralink, he led and mentored the process engineering team, and under his leadership, the team designed and implemented probes for brain-machine interface systems. Dr. Diaz-Botia earned his Ph.D. in Bioengineering from the joint program at the University of California Berkeley and the University of California San Francisco.
"We are thrilled to have such a highly regarded neural engineering expert to lead our development team," says Rosa. "Camilo brings in-depth knowledge and expertise in the design of implantable thin-film electrodes. His responsibilities and experience at Neuralink, from research and development to manufacturing, expand the depth and breadth of our capabilities to further develop NeuroOne's portfolio of thin film electrode technology. As we continue to pursue our vision of developing combination diagnostic and therapeutic electrode technology, we expect Camilo's leadership and experience will contribute significantly to helping us achieve these goals."
"I believe NeuroOne's focus on bringing thin-film devices to patients will have a significant impact in their overall clinical experience. For many years, thin-film technologies have been utilized in academic settings and have matured enough to address a number of clinical needs today. I am excited to be a part of the ongoing development of NeuroOne's thin-film electrodes and furthering NeuroOne's goal of making these devices commercially available." Said Dr. Diaz-Botia.